Approvals last year included rare disease treatments, new oncology drugs, Eli Lilly’s Kisunla, and Mesoblast's Ryoncil.

Dr. Aseem Malhotra, a cardiologist and public health campaigner based in London, says Americans' foods are fueling chronic ...

A new research study highlights the significant health risks associated with dust storms, revealing an increase in emergency department (ED) visits for respiratory and cardiovascular conditions ...

People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...

Individuals with asthma and chronic obstructive pulmonary disease (COPD) were more vulnerable than healthy controls to ...

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...

Every year, 900,000 Americans are caught by surprise by the symptoms of a pulmonary embolism: a sudden shortness of breath, ...

Recent research published in The Lancet Respiratory Medicine confirms that emphysema was detected in 24% to 31% of patients undergoing lung cancer screening. This means that for millions of Americans, ...

In a recent study, Mass General Brigham researchers demonstrated that through low-cost genetic samples that can be obtained from a cheek swab or blood test, they can improve identification of people ...

application for HBM9378/SKB378 (also known as WIN378), a fully human antibody targeting thymic stromal lymphopoietin (TSLP), for the treatment of chronic obstructive pulmonary disease (COPD). COPD is ...